Delayed
NSE India S.E.
01:20:20 16/05/2024 pm IST
5-day change
1st Jan Change
5,241
INR
-0.10%
+3.47%
+0.78%
This article is reserved for members
Not a member ?
Free registration
Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak
16/04
CI
Alkem Laboratories Forms Subsidiary for Medical Devices Business
28/03
MT
Alkem Laboratories Limited Announces Incorporation of Subsidiary Alkem Medtech Private Limited
28/03
CI
Alkem Laboratories Gets 10 Observations from US FDA After Baddi, India Unit Inspection
28/03
MT
Norway's Biosergen Secures Indian Regulatory Approval for Clinical Trial of Fungal Infections Therapy
12/02
MT
Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,470 From INR3,960, Keeps at Underperform
12/02
MT
Transcript : Alkem Laboratories Limited, Q3 2024 Earnings Call, Feb 09, 2024
09/02
Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
09/02
CI
Indian Equities Close Higher on Friday, Lifted by IT Stocks
12/01
MT
Alkem Laboratories Names Successor to Outgoing CFO
12/01
MT
Alkem Laboratories Limited Announces CFO Changes
12/01
CI
Heritage Global, Investors Acquire Pharmaceutical Plant from Alkem Laboratories
12/01
MT
Federal Machinery & Equipment Co., Heritage Global Partners, Inc., New Mill Capital LLC, Keith Machinery Corp acquired Pharmaceutical Site in Fenton Missouri from Alkem Laboratories Limited.
11/01
CI
Alkem Laboratories Limited Appoints Ashish Sehgal to Hold Senior Management Position in the Company Effective 15 December 2023
15/12
CI
Alkem Laboratories Limited Submits Clinical Trial Application to Central Drugs Standard Control Organization in India
12/12
CI
Alkem Laboratories Limited Submits Clinical Trial Application for First Patient Study with Bsg005 in Invasive Fungal Infections in India as A Rescue Therapy
12/12
CI
Biosergen's Indian Partner Seeks Approval for Clinical Trial of Antifungal Drug Candidate
12/12
MT
Alkem Laboratories Limited Appoints Kaustav Banerjee to Hold Senior Management Position
05/12
CI
Alkem Laboratories Gets Three Observations from US FDA After Mandva, India Unit Inspection
04/12
MT
Alkem Laboratories Appoints Sanchit Bansal to Senior Management Position
30/11
CI
Alkem Laboratories Limited Appoints Madhurima Singh, Executive Director
23/11
CI
Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR4,963 From INR3,632
09/11
MT
Jefferies Adjusts Alkem Laboratories’ Price Target to INR3,600 From INR3,550, Keeps at Underperform
08/11
MT
Alkem Laboratories' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 6%
08/11
MT
Transcript : Alkem Laboratories Limited, Q2 2024 Earnings Call, Nov 07, 2023
07/11
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Alkem Laboratories Limited is an India-based company, which is engaged in the pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Companyâs product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The Company operates through a segment, Pharmaceuticals. It has approximately 21 manufacturing facilities at multiple locations in India and the United States. The Company has approximately 800 brands and operates in 40 countries.
More about the company
Last Close Price
5,247
INR
Average target price
5,184
INR
Spread / Average Target
-1.20%
Consensus
1st Jan change
Capi.
+0.78% 7.52B +35.01% 709B +30.74% 595B -2.60% 367B +20.83% 334B +5.69% 289B +14.36% 239B +9.31% 211B -3.44% 203B +10.77% 171B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
#252525**/registration/member/**Blanc**1**7**To continue browsing, please register!**#ffffff50**14px**#33d251**